Search
Close this search box.
Search
Close this search box.

Hemo Alliance Newsletters

Legal Update, December 2021

Legal Update

Not the Old, Not the New, but the Necessary: Legal Review of 2021
by Elizabeth “Issie” Karan, Legal Counsel

2021 brought new but also familiar opportunities and challenges in the hemophilia treatment center (HTC) compliance and legal world. While Hemophilia Alliance members always ask insightful questions amidst the larger healthcare landscape’s surprising turns, the pressures of operating a highly regulated grant program in a complex industry often return the legal team’s work to the same authorities and themes. Through both the known and novel, the Alliance legal team works to distill and translate the miasma into useful and actionable guidance for HTCs.

On new subjects, the legal team often collaborated with other members of the Alliance team. We assisted the policy and payer team in preparing for implementation of the Hemophilia SNF Access to Care Act. We advised the Alliance on issues related to DDAVP. We began to prepare for gene therapy by developing legal templates. We provided analysis of state pharmacy laws impacting HTCs’ operations. Additionally, we tracked litigation related to the 340B Program. Although many issues were different, the cooperation and camaraderie of the Alliance team remains.

On the familiar topics, the legal team fielded many members’ questions related to federal grants and the 340B Program. Among other things, in the grants arena, we provided technical assistance on the use of program income, reasonable indirect cost rates, and salary limitations. For 340B, we helped members with policies and procedures, audit protocols, and operationalizing the patient definition. Through it all, we encouraged HTCs to connect with their regional leadership when appropriate and educated members through presentation.

We know 2022 will bring both unexpected and known inquiries and look forward to helping guide the Alliance and its members to the right answers.

Also in this Issue…

Notes from Joe
· Looking Back, Planning Ahead

Washington Update
· Year in Review

Payer Update
· Payer Team Update

Alliance Board Update
· Update on New and Departing Alliance Board Members

Alliance Update
· Operations Team Update
· 2022 Spring Alliance Members Meeting Schedule

Notes from the Community
· Hemophilia Alliance Foundation Announces 2022 Project/Patient Assistance Grant

Team Alliance Contact Information

We work for you! Please don’t hesitate to contact any of us with any questions or concerns:

NameEmailPhone
Jeff Blakejeff@hemoalliance.org317-657-5913
Jennifer Borrillo, MSW, LCSW, MBAborrillo@hemoalliance.org504-376-5282
Jeff Amondamond@hemoalliance.org608-206-3132
Jennifer Andersjennifer@hemoalliance.org954-218-8509
Angela Blue, MBAangela@hemoalliance.org651-308-3902
Karen Bowe-Hausekaren@hemoalliance.org717-571-0266
Zack Duffyzack@hemoalliance.org503-804-2581
Michael B. GlombMGlomb@ftlf.com202-466-8960
Johanna Gray, MPAjgray@artemispolicygroup.com703-304-8111
Kiet Huynhkiet@hemoalliance.org917-362-1382
Elizabeth Karanelizabeth@karanlegalgroup.com612-202-3240
Kollet Koulianos, MBAkollet@hemoalliance.org309-397-8431
Roland P. Lamy, Jr.roland@hemoalliance.org603-491-0853
Dr. George L. Oestreich, Pharm.D., MPAgeorge@gloetal.com573-230-7075
Theresa Parkertheresa@hemoalliance.org727-688-2568
Mark Plencnermark@hemoalliance.org701-318-2910
Ellen Rikereriker@artemispolicygroup.com202-257-6670